ChristopherJGibsonMD

Clinical Fellow in Medicine, Brigham and Women's Hospital

Dr. Gibson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Yale School of MedicineClass of 2009

PubMed

81 citations
Prediction of risk for myeloid malignancy in clonal hematopoiesis.
Lachelle D Weeks, Abhishek Niroula, Donna Neuberg, Waihay Wong, R Coleman Lindsley
NEJM Evidence. 2023-05-01
6 citations
Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes.
Harrison K Tsai, Christopher J Gibson, H Moses Murdock, Phani Davineni, Marian H Harris
Blood Advances. 2022-07-26
418 citations
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature Reviews. Cancer. 2017-01-01

Abstracts/Posters

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
Christopher J. Gibson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloi...
Christopher J. Gibson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response
Christopher J. Gibson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019